HZNP Insider Trading
Notice: This stock is marked as potentially delisted. It may not be actively trading.
Insider Ownership Percentage: 2.20%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00
Horizon Therapeutics Public Insider Trading History Chart
This chart shows the insider buying and selling history at Horizon Therapeutics Public by year and by quarter.
Skip ChartChart Data in Insider Trading History Table
Horizon Therapeutics Public Share Price & Price History
Current Price: $116.30
Price Change: +0.30 (1.20%)
As of 10/6/2023 01:00 AM ET
Horizon Therapeutics Public Insider Trading History
Horizon Therapeutics Public Institutional Trading History
Data available starting January 2016
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. Its portfolio comprises 12 medicines in the areas of rare diseases, gout, ophthalmology, and inflammation. It markets TEPEZZA (teprotumumab-trbw) for intravenous infusion; KRYSTEXXA (pegloticase injection) for intravenous infusion; RAVICTI (glycerol phenylbutyrate) oral liquid; PROCYSBI (cysteamine bitartrate) delayed-release capsules and granules for oral use; ACTIMMUNE (interferon gamma-1b) injection for subcutaneous use; BUPHENYL (sodium phenylbutyrate) tablets and powder for oral use; QUINSAIR (levofloxacin) solution for inhalation; and UPLIZNA (inebilizumab-cdon) injection for intravenous use. The company also markets PENNSAID (diclofenac sodium topical solution) for topical use; DUEXIS (ibuprofen/famotidine) tablets for oral use; RAYOS (prednisone) delayed-release tablets for oral use; and VIMOVO (naproxen/esomeprazole magnesium) delayed-release tablets for oral use. It has collaboration agreements with HemoShear Therapeutics, LLC; Alpine Immune Sciences, Inc.; Halozyme Therapeutics, Inc.; Arrowhead Pharmaceuticals, Inc.; Q32 Bio Inc.; and Xeris Biopharma Holdings, Inc. The company was formerly known as Horizon Pharma Public Limited Company and changed its name to Horizon Therapeutics Public Limited Company in May 2019. Horizon Therapeutics Public Limited Company was founded in 2005 and is headquartered in Dublin, Ireland.
Read More on Horizon Therapeutics Public
Today's Range
Now: $116.30
Low: $116.30
High: $116.30
50 Day Range
MA: $115.72
Low: $112.60
High: $116.30
52 Week Range
Now: $116.30
Volume
N/A
Average Volume
2,498,525 shs
Market Capitalization
$26.63 billion
P/E Ratio
62.19
Dividend Yield
N/A
Beta
1.03